Faculty Profile | Academic Online

Faculty

Institution

Unit

Venue

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

320P Real-World Study of Treatment Patterns and Outcomes in Hr+/Her2- Metastatic Breast Cancer Patients After Progression on Cdk4/6 Inhibitor Therapy. ESMO Open (2025)

breast oncologymetastasisradiation oncologymolecular cancertreatment patternsreal-world studycdk4/6 inhibitor therapymedicinetherapeutic targetscancer managementcancer cellscancer treatmentcancer careoncologybreast cancer

Abstract Ps6-04: Eliminating Breast Surgery for Invasive, Hormone-Positive Breast Cancers With an Exceptional Response to Endocrine Therapy and Ablative Radiotherapy: A Single-Arm, Phase 2 Trial. Clinical Cancer Research (2025)

breast oncologyradiation oncologyendocrine-related cancersablative radiotherapysurgical oncologyabstract ps6-04gynecologybreast surgerycancer careoncologybreast cancereliminating breast surgery

A New Cure Model Accounting for Longitudinal Data and Flexible Patterns of Hazard Ratios Over Time. Statistical Methods in Medical Research (2025)

Can XieXuelin HuangRuosha LiYu ShenNicholas J ShortKapil N Bhalla

biostatisticspublic healthstatistical methodologyflexible patternslongitudinal datahazard ratiosapplied statisticslongitudinal studiesstatistical analysisclinical researchsurvival analysisstatistics

Conformal Predictive Intervals in Survival Analysis. Biometrics (2025)

biostatisticsstatistical methodologystatisticsapplied statisticssurvival analysisquantitative science studiesmortality

Conformal Predictive Intervals in Survival Analysis: A Resampling Approach. Biometrics (2025)

biostatisticsstatistical methodologyprognostic evaluationprognosismedical statisticsresampling approachcomputational statisticsapplied statisticssurvival analysiscancer carestatistics

Phase I Trial of Hydroxychloroquine to Enhance Palbociclib and Letrozole Efficacy in Er+/Her2− Breast Cancer. npj Breast Cancer (2025)

future medicinal chemistrybreast oncologyer+/her2− breast cancerradiation oncologyletrozole efficacymolecular cancercancer researchpharmacologypharmacotherapycancer treatmentoncologybreast cancer

Predicting Pathologic ≥N2 Disease in Women With Breast Cancer. npj Breast Cancer (2025)

breast oncologygynecologic oncologypathologycancer riskbreast imagingoncologybreast cancer

Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in Her2-Negative Patients Using Shape Restricted Modeling. Scientific Reports (2025)

breast oncologybiostatisticsgynecologic oncologyendocrine-related cancersbreast cancer prognosisher2-negative patientscancer discoverysystems biologyovarian cancerbreast cancer

Reconsidering the Definition of Triple-Negative Breast Cancer in the Immune Checkpoint Inhibitor Era: An Optimal Cut-Off Value for Hormone Receptor Percentage of Her2-Negative Invasive Breast Cancer. British Journal of Cancer (2025)

breast oncologyradiation oncologyoptimal cut-off valuecancer immunotherapyimmunologymolecular cancerimmune checkpoint inhibitorstriple-negative breast cancercancer treatmenthormone receptor percentagecancer carebreast cancer

Sequence of Therapy Impact on Older Women With Comorbidities and Triple-Negative or Her2-Positive Breast Cancer. npj Breast Cancer (2025)

breast oncologygynecologic oncologyradiation oncologyolder womenwomen's healththerapy impactgynecologycancer managementcancer careoncologybreast cancerher2-positive breast cancer

1
2
3
4
5
27
10 / page

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

320P Real-World Study of Treatment Patterns and Outcomes in Hr+/Her2- Metastatic Breast Cancer Patients After Progression on Cdk4/6 Inhibitor Therapy. ESMO Open (2025)

breast oncologyradiation oncologyendocrine-related cancersablative radiotherapysurgical oncologyabstract ps6-04gynecologybreast surgerycancer careoncologybreast cancereliminating breast surgery

A New Cure Model Accounting for Longitudinal Data and Flexible Patterns of Hazard Ratios Over Time. Statistical Methods in Medical Research (2025)

Can XieXuelin HuangRuosha LiYu ShenNicholas J ShortKapil N Bhalla

biostatisticspublic healthstatistical methodologyflexible patternslongitudinal datahazard ratiosapplied statisticslongitudinal studiesstatistical analysisclinical researchsurvival analysisstatistics

Conformal Predictive Intervals in Survival Analysis. Biometrics (2025)

biostatisticsstatistical methodologystatisticsapplied statisticssurvival analysisquantitative science studiesmortality

Conformal Predictive Intervals in Survival Analysis: A Resampling Approach. Biometrics (2025)

biostatisticsstatistical methodologyprognostic evaluationprognosismedical statisticsresampling approachcomputational statisticsapplied statisticssurvival analysiscancer carestatistics

Phase I Trial of Hydroxychloroquine to Enhance Palbociclib and Letrozole Efficacy in Er+/Her2− Breast Cancer. npj Breast Cancer (2025)

future medicinal chemistrybreast oncologyer+/her2− breast cancerradiation oncologyletrozole efficacymolecular cancercancer researchpharmacologypharmacotherapycancer treatmentoncologybreast cancer

Predicting Pathologic ≥N2 Disease in Women With Breast Cancer. npj Breast Cancer (2025)

breast oncologygynecologic oncologypathologycancer riskbreast imagingoncologybreast cancer

Reassessing Estrogen Receptor Expression Thresholds for Breast Cancer Prognosis in Her2-Negative Patients Using Shape Restricted Modeling. Scientific Reports (2025)

breast oncologybiostatisticsgynecologic oncologyendocrine-related cancersbreast cancer prognosisher2-negative patientscancer discoverysystems biologyovarian cancerbreast cancer

Sequence of Therapy Impact on Older Women With Comorbidities and Triple-Negative or Her2-Positive Breast Cancer. npj Breast Cancer (2025)

breast oncologygynecologic oncologyradiation oncologyolder womenwomen's healththerapy impactgynecologycancer managementcancer careoncologybreast cancerher2-positive breast cancer

1
2
3
4
5
27
10 / page